Wu J - Search Results

1

Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.

Wang K, Li L, Franch-Expósito S, Le X, Tang J, Li Q, Wu Q, Bassaganyas L, Camps J, Zhang X, Li H, Foukakis T, Xiang T, Wu J, Ren G. Wang K, et al. Among authors: wu q, wu j. Mol Oncol. 2022 Jun;16(12):2413-2431. doi: 10.1002/1878-0261.13043. Epub 2021 Jul 29. Mol Oncol. 2022. PMID: 34146382 Free PMC article.

2

[Peripheral blood mutated p53 DNA and its clinical value in human breast cancer].

Di GH, Liu G, Wu J, Shen ZZ, Shao ZM. Di GH, et al. Among authors: wu j. Zhonghua Zhong Liu Za Zhi. 2003 Mar;25(2):137-40. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12795838 Chinese.

3

[In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].

Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Lu LJ, Liu G, Shen ZZ, Ding J, Shao ZM. Hou YF, et al. Among authors: wu j. Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):389-92. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16188119 Chinese.

4

[Biological significance of E-cadherin in an inflammatory breast carcinoma cell line].

Dong HM, Liu G, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM. Dong HM, et al. Among authors: wu j. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):4-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737610 Chinese.

5

Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Dong HM, Liu G, Hou YF, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM. Dong HM, et al. Among authors: wu j. J Cancer Res Clin Oncol. 2007 Feb;133(2):83-92. doi: 10.1007/s00432-006-0140-6. Epub 2006 Aug 24. J Cancer Res Clin Oncol. 2007. PMID: 16932944

6

[Clinicopathological significance of aromatase expression in breast cancers].

Lu JS, Li HC, Cao DC, Di GH, Wu J, Shen KW, Shen ZZ, Shao ZM. Lu JS, et al. Among authors: wu j. Zhonghua Wai Ke Za Zhi. 2006 Oct 1;44(19):1318-21. Zhonghua Wai Ke Za Zhi. 2006. PMID: 17217816 Chinese.

7

Clinical significance of aromatase protein expression in axillary node negative breast cancer.

Lu J, Li H, Cao D, Di G, Wu J, Sheng K, Han Q, Shen Z, Shao Z. Lu J, et al. Among authors: wu j. J Cancer Res Clin Oncol. 2007 Jun;133(6):401-9. doi: 10.1007/s00432-006-0186-5. Epub 2007 Jan 12. J Cancer Res Clin Oncol. 2007. PMID: 17219197

8

Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: wu j. Breast. 2007 Jun;16(3):307-15. doi: 10.1016/j.breast.2006.12.011. Epub 2007 Feb 12. Breast. 2007. PMID: 17293115

9

[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine].

Fan J, Lu JS, Yin WJ, Lei W, Wu FY, Wu J, Hou YF, Li DQ, Di GH, Shen ZZ, Shao ZM. Fan J, et al. Among authors: wu fy, wu j. Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):886-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533736 Chinese.

10

[Surgical management of early breast cancer].

Di GH, Wu J, Yu KD, Lu JS, Shen KW, Shen ZZ, Shao ZM. Di GH, et al. Among authors: wu j. Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):62-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17575698 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76,771 results

Search Page

Filters